Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
While formal clinical trials in humans are limited and the compound is not FDA-approved, early preclinical studies and anecdotal reports suggest it may play a role in supporting the bodys natural healing processes
The principal site of absorption is the upper jejunum
Appetite stimulation is minimal or absent in most users
the peak plasma level of the active metabolite is typically achieved an hour after oral administration
Ellison M et al (2016): Prolonged Paralysis Following Emergent Cesarean Section with Succinylcholine Despite Normal Dibucaine Number
Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer
US$ 26.00
US$ 20.01
US$ 20.40
US$ 20.40
US$ 28.83
US$ 21.20
US$ 21.04
US$ 28.74
